Novadiscovery
Gregoire Boutonnet currently serves as Co-Chief Executive Officer and Chief Operating Officer at Nova In Silico since February 2021, focusing on operational excellence, strategic growth, business development, and leading the Modeling and Simulation team. Previously, Boutonnet was Chief Strategy Officer at Experty.io, where the company provided a real-time paid-communication solution utilizing blockchain technology. In earlier roles, Boutonnet held the position of Chief Marketing and Product Officer at CIRPACK, Chief Marketing Officer for Product Strategy at Amplement, and founded Andrexen, specializing in unified communication platforms for next-generation voice services. Boutonnet holds a Master’s degree in Fundamental Physics from Pierre and Marie Curie University.
Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.